| 1 |
1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 2 |
11 Beta-Hydroxysteroid Dehydrogenase (11 HSD) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 3 |
11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11 HSD1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 4 |
20s Proteasome Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 5 |
30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 6 |
4-1BB receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 7 |
50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 8 |
5-Alpha Reductase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 9 |
5-HT1 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 10 |
5-HT1 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 11 |
5-HT1A Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 12 |
5-HT1B Agonist - Pipeline Insight, 2022 |
Report Link
|
| 13 |
5-HT1B Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 14 |
5-HT1D Agonist - Pipeline Insight, 2022 |
Report Link
|
| 15 |
5-HT2 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 16 |
5-HT2 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 17 |
5-HT2A Agonist - Pipeline Insight, 2022 |
Report Link
|
| 18 |
5-HT2B Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 19 |
5-HT2C Agonist - Pipeline Insight, 2022 |
Report Link
|
| 20 |
5-HT2C Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 21 |
5-HT4 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 22 |
5-HT4 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 23 |
5-HT4 Partial Agonist - Pipeline Insight, 2022 |
Report Link
|
| 24 |
5-HT6 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 25 |
5-HT7 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 26 |
GABAB Agonist - Pipeline Insight, 2022 |
Report Link
|
| 27 |
Galectin Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 28 |
Gamma Secretase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 29 |
Ghrelin Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 30 |
Glucagon Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 31 |
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 32 |
Glucocorticoid induced tumor necrosis factor - Pipeline Insight, 2022 |
Report Link
|
| 33 |
Glucocorticoid Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 34 |
Glucokinase Activators - Pipeline Insight, 2022 |
Report Link
|
| 35 |
Glucosylceramide Synthase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 36 |
Glutamate Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 37 |
Glycan Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 38 |
Glycine Transporter Type-1 (Glyt-1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 39 |
Glycogen Synthase Kinase 3 (GSK-3) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 40 |
GM-CSF Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 41 |
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 42 |
G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 43 |
Growth Hormone (GH) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 44 |
Growth Hormone Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 45 |
Guanylate Cyclase (Guanyl Cyclase or Guanylyl Cyclase or GC) Activators - Pipeline Insight, 2022 |
Report Link
|
| 46 |
Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2022 |
Report Link
|
| 47 |
H Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 48 |
H 2 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 49 |
H 3 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 50 |
H 4 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 51 |
Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 52 |
Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 53 |
Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 54 |
Methionine Aminopeptidase 2 (Metap2) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 55 |
mGlu 2/3 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 56 |
mGlu 2/3/5 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 57 |
mGlu5 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 58 |
Mitochondrial Electron Transport Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 59 |
Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 60 |
Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 61 |
Monoamine Oxidase Inhibitor (MAOIs) - Pipeline Insight, 2022 |
Report Link
|
| 62 |
Monoamine Oxidase B (MAO-B) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 63 |
mTORC-1 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 64 |
mTORC-2 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 65 |
Mu Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 66 |
Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 67 |
Muscarinic Acetylcholine Receptor (mAChR) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 68 |
Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 69 |
Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 70 |
Muscarinic Agonist - Pipeline Insight, 2022 |
Report Link
|
| 71 |
Muscarinic M1 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 72 |
Myostatin Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 73 |
Neurokinin (NK) Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 74 |
Neurokinin 1 (NK1) Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 75 |
Neuronal Nitric Oxide Synthase (nNOS or Type I NOS) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 76 |
Heat Shock Protein (Hsp) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 77 |
Hedgehog Signaling Pathway Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 78 |
Hepatitis C Virus (HCV) Protease Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 79 |
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 80 |
Hepcidin Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 81 |
Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 82 |
HIF-1 Alpha Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 83 |
Interleukin-23 (IL-23) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 84 |
HIV Attachment Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 85 |
Interleukin-4 (IL-4) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 86 |
Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 87 |
Interleukin-5 (IL-5) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 88 |
Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 89 |
Interleukin-8 (IL-8) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 90 |
Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 91 |
Ionotropic Glutamate Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 92 |
IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 93 |
IL-6 Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 94 |
Mayus Kinase (JAK) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 95 |
Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 96 |
Mayus Kinase 1 (JAK1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 97 |
Inhibitor of Apoptosis (IAP) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 98 |
Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 99 |
Insulin Like Growth Factor (IGF) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 100 |
Kainate Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 101 |
Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2022 |
Report Link
|
| 102 |
Kallikrein Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 103 |
Integrase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 104 |
Kappa Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 105 |
Integrin Alpha 4beta1/Very Late Antigen-4 (VLA-4) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 106 |
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2022 |
Report Link
|
| 107 |
interleukin Agonist - Pipeline Insight, 2022 |
Report Link
|
| 108 |
Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2022 |
Report Link
|
| 109 |
Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 110 |
LAG-3 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 111 |
Interleukin-10 (IL-10) Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 112 |
Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 113 |
Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 114 |
Leukotriene Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 115 |
Interleukin-13 (IL-13) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 116 |
Leukotriene D4 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 117 |
Interleukin-17 (IL-17) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 118 |
Neutrophil Elastase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 119 |
Lipoxygenase Inhibitor (LOX Inhibitor) - Pipeline Insight, 2022 |
Report Link
|
| 120 |
Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 121 |
NMDA Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 122 |
Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 123 |
Non Selective COX Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 124 |
PI3K/mTOR Pathway Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 125 |
Lysine Specific Demethylase 1 (LSD-1) Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 126 |
Non-Receptor Tyrosine Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 127 |
Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 128 |
Pim Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 129 |
Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 130 |
Non-Structural Protein 5 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 131 |
Plasmin Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 132 |
Noradrenaline Transporter (NAT or Norepinephrine Transporter or NET) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 133 |
Plasminogen Activator Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 134 |
Notch Signaling Pathway Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 135 |
Plasminogen Activator Inhibitor-1 (PAI-1) - Pipeline Insight, 2022 |
Report Link
|
| 136 |
Nrf2 Pathway Activators - Pipeline Insight, 2022 |
Report Link
|
| 137 |
Plasminogen Activators - Pipeline Insight, 2022 |
Report Link
|
| 138 |
Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2022 |
Report Link
|
| 139 |
Platelet Derived Growth Factor Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 140 |
Opioid Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 141 |
Polo-Like Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 142 |
Orexin Receptor (Hypocretin Receptor) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 143 |
Polo-Like Kinase 1 (PLK1 ) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 144 |
Ornithine Decarboxylase (ODC) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 145 |
Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 146 |
OX-40 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 147 |
Potassium Channel Openers - Pipeline Insight, 2022 |
Report Link
|
| 148 |
P2X7 Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 149 |
PPAR-Beta / Delta Agonist - Pipeline Insight, 2022 |
Report Link
|
| 150 |
P2Y12 Platelet ADP Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 151 |
Progesterone Receptor (PR) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 152 |
p70S6 Kinase (p70S6K or 70-kDa Ribosomal Protein S6 Kinase) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 153 |
Progesterone Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 154 |
Parathyroid Hormone Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 155 |
Prolactin Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 156 |
PDE Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 157 |
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 158 |
PDE 1 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 159 |
Prostaglandin Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 160 |
PDE 10 inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 161 |
Protein Kinase C (PKC) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 162 |
Penicillin-Binding Proteins (PBPs) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 163 |
Protein-Tyrosine Phosphatase (PTP) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 164 |
Peroxisome Proliferator-Activated Receptor (PPAR) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 165 |
Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 166 |
Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 167 |
Purinergic Receptor (Purinoceptor) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 168 |
Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 169 |
Renin Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 170 |
RET (Ret Proto-Oncogene) protein Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 171 |
Retinoic Acid Receptors (RARs) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 172 |
Reversible Anticholinesterases - Pipeline Insight, 2022 |
Report Link
|
| 173 |
TGF-Beta-1 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 174 |
TGF-Beta-2 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 175 |
Tie-2 modulators - Pipeline Insight, 2022 |
Report Link
|
| 176 |
Tie-2 Receptor Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 177 |
TIM-3 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 178 |
Toll- Like Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 179 |
Toll-Like Receptor 4 (TLR-4) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 180 |
Toll-Like Receptor 7, 8 (TLR-8) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 181 |
Toll-Like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2022 |
Report Link
|
| 182 |
Toll-Like Receptor Modulators - Pipeline Insight, 2022 |
Report Link
|
| 183 |
Topoisomerase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 184 |
TRAIL Receptor 1 & Receptor 2 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 185 |
Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 186 |
Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 187 |
Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 188 |
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 189 |
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 190 |
TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 191 |
Tumor Necrosis Factor Alpha (TNF-a) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 192 |
Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 193 |
Ubiquitin conjugating enzyme Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 194 |
Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 195 |
Vascular Endothelial Growth Factor Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 196 |
Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 197 |
RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 198 |
RON (Recepteur d'origine Nantais) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 199 |
Sclerostin Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 200 |
Secretase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 201 |
Selectin Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 202 |
Selective COX-2 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 203 |
Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 204 |
Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2022 |
Report Link
|
| 205 |
Serotonin Transporter Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 206 |
Sigma Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 207 |
Sodium Dependent Glucose Transporter 1 (SGLT1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 208 |
Somatostatin Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 209 |
Sphingosine 1-Phosphate (S1P) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 210 |
Sphingosine 1-Phosphate (S1P) Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 211 |
Squalene Epoxidase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 212 |
SRC Family Kinases (SFK) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 213 |
Sterol 14 Alpha-Demethylase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 214 |
Superoxide Dismutase (SOD) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 215 |
T Cell Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 216 |
Tau Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 217 |
Telomerase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 218 |
Tetrahydrofolate Dehydrogenase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 219 |
TGF-Beta Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 220 |
Vascular Endothelial Growth Factor A (VEGF-A) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 221 |
Vasopressin Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 222 |
Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 223 |
Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 224 |
Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 225 |
VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 226 |
Viral RNA Polymerase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 227 |
5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2022 |
Report Link
|
| 228 |
Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 229 |
Acetylcholine Receptor (AChR) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 230 |
Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2022 |
Report Link
|
| 231 |
Adenosine A1 Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 232 |
Alpha-1 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 233 |
Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2022 |
Report Link
|
| 234 |
Adenosine A1 Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 235 |
Voltage-Gated Sodium Channel Blockers - Pipeline Insight, 2022 |
Report Link
|
| 236 |
Alpha-1A Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 237 |
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 238 |
Anti-CD33 Antibody - Pipeline Insight, 2022 |
Report Link
|
| 239 |
Wnt Signaling Pathway Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 240 |
Alpha-2 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 241 |
Adenosine A2A Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 242 |
Xanthine Oxidase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 243 |
Anti-CD37 Antibody - Pipeline Insight, 2022 |
Report Link
|
| 244 |
Alpha-2 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 245 |
Adenosine A2A Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 246 |
Alpha-Amylase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 247 |
Anti-CD38 Antibody - Pipeline Insight, 2022 |
Report Link
|
| 248 |
Beta-1 Receptors Agonist - Pipeline Insight, 2022 |
Report Link
|
| 249 |
Adenosine A2B Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 250 |
Anti-CD40 Antibody - Pipeline Insight, 2022 |
Report Link
|
| 251 |
Alpha-Synuclein (alphaSyn or SNCA) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 252 |
Adenosine A3 Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 253 |
Beta-2 Receptors Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 254 |
Anti-CD52 Antibody - Pipeline Insight, 2022 |
Report Link
|
| 255 |
AMPA Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 256 |
Adenosine A3 Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 257 |
Beta-2 Receptors Agonist - Pipeline Insight, 2022 |
Report Link
|
| 258 |
Anti-CD80 Antibody - Pipeline Insight, 2022 |
Report Link
|
| 259 |
Adenosine Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 260 |
Amyloid Protein Blockers - Pipeline Insight, 2022 |
Report Link
|
| 261 |
Beta-3 Receptors Agonist - Pipeline Insight, 2022 |
Report Link
|
| 262 |
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2022 |
Report Link
|
| 263 |
Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 264 |
Beta-Lactamase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 265 |
Adrenergic Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 266 |
Anti-Lymphotoxin - Pipeline Insight, 2022 |
Report Link
|
| 267 |
Androgen Agonist - Pipeline Insight, 2022 |
Report Link
|
| 268 |
Adrenergic Uptake Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 269 |
Blood Coagulation Factor Activators - Pipeline Insight, 2022 |
Report Link
|
| 270 |
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022 |
Report Link
|
| 271 |
Androgen Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 272 |
Bradykinin Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 273 |
Akt1 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 274 |
Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 275 |
Angiopoietin Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 276 |
Aldose Reductase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 277 |
Bradykinin Receptor B1 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 278 |
Apoptosis Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 279 |
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 280 |
Aldosterone Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 281 |
Bradykinin Receptor B2 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 282 |
Arginine Depletors - Pipeline Insight, 2022 |
Report Link
|
| 283 |
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 284 |
BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors - Pipeline Insight, 2022 |
Report Link
|
| 285 |
Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 286 |
ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 287 |
Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2022 |
Report Link
|
| 288 |
Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2022 |
Report Link
|
| 289 |
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2022 |
Report Link
|
| 290 |
ATPase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 291 |
Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 292 |
Alpha Glucosidase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 293 |
Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 294 |
Aurora Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 295 |
Angiotensin Modulators - Pipeline Insight, 2022 |
Report Link
|
| 296 |
Alpha Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 297 |
C1 Esterase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 298 |
Autophagy modulators - Pipeline Insight, 2022 |
Report Link
|
| 299 |
Angiotensin Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 300 |
Alpha Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 301 |
C5a Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 302 |
Anti GM-CSF Antibody - Pipeline Insight, 2022 |
Report Link
|
| 303 |
B-Cell Activating Factor (BAFF) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 304 |
Alpha v Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 305 |
Bcl-xL Protein Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 306 |
Anti-CD152 Antibody - Pipeline Insight, 2022 |
Report Link
|
| 307 |
Alpha v Beta 3 Integrin Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 308 |
Cannabinoid Agonist - Pipeline Insight, 2022 |
Report Link
|
| 309 |
Anti-CD19 Antibody - Pipeline Insight, 2022 |
Report Link
|
| 310 |
Bcr-Abl Tyrosine Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 311 |
Cannabinoid Receptor Type 1 (CB1) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 312 |
Alpha v Beta 5 Integrin Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 313 |
Benzodiazepine Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 314 |
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2022 |
Report Link
|
| 315 |
Cannabinoid Receptor Type 1 (CB1) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 316 |
Alpha-1 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 317 |
Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 318 |
Beta Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 319 |
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022 |
Report Link
|
| 320 |
Carbonic Anhydrase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 321 |
Beta Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 322 |
Anti-CD28 Antibody - Pipeline Insight, 2022 |
Report Link
|
| 323 |
Carnitine Palmitoyltransferase I (CPT 1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 324 |
Anti-CD3 Antibody - Pipeline Insight, 2022 |
Report Link
|
| 325 |
Beta Secretase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 326 |
Beta Selective Thyroid Hormone Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 327 |
Casein Kinase 2 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 328 |
Beta-1 Receptors Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 329 |
Caspase 3 (CPP32, Apopain or YAMA) Activators - Pipeline Insight, 2022 |
Report Link
|
| 330 |
Caspases Activators - Pipeline Insight, 2022 |
Report Link
|
| 331 |
Caspases Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 332 |
Catechol-O-methyltransferase (COMT) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 333 |
Cathepsin K/S Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 334 |
Cathepsin K Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 335 |
Cathepsin S inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 336 |
Cholesterol Absorption Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 337 |
CCR Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 338 |
Cholesterylester Transfer Protein (CETP) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 339 |
CCR1 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 340 |
C-Raf Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 341 |
CCR2 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 342 |
CRF1 Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 343 |
CCR3 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 344 |
Diglyceride Acyltransferase (DGAT) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 345 |
CXCR4 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 346 |
CCR4 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 347 |
Dihydroorotate Dehydrogenase (DHODH) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 348 |
Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 349 |
CCR5 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 350 |
DNA Methyltransferase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 351 |
Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 352 |
CD (Cluster of Differentiation) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 353 |
Fatty Acid Synthase (FAS) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 354 |
DNA-Dependent RNA Polymerase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 355 |
Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 356 |
CD 19 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 357 |
Dopaminergic Agonist - Pipeline Insight, 2022 |
Report Link
|
| 358 |
Fc-Gamma Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 359 |
Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 360 |
CD 3 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 361 |
Dopaminergic system Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 362 |
Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 363 |
CD 33 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 364 |
DP1 Receptor (Prostaglandin D2 receptor) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 365 |
Cyclophilin Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 366 |
Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 367 |
CD 40 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 368 |
DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 369 |
CD152 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 370 |
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 371 |
Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 372 |
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 373 |
Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2022 |
Report Link
|
| 374 |
CD40 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 375 |
Focal Adhesion Kinase (FAK) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 376 |
Cytochrome P450 Superfamily (CYP or CYP450) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 377 |
Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 378 |
Cell Wall Synthesis Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 379 |
Fusion Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 380 |
Cytochrome P450 17 (CYP17) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 381 |
D Agonist - Pipeline Insight, 2022 |
Report Link
|
| 382 |
cFMS Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 383 |
G2 Checkpoint Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 384 |
Checkpoint Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 385 |
D Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 386 |
GABA Receptor Agonist - Pipeline Insight, 2022 |
Report Link
|
| 387 |
GABA Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 388 |
Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 389 |
D1 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 390 |
D1 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 391 |
GABA Receptor Modulators - Pipeline Insight, 2022 |
Report Link
|
| 392 |
Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 393 |
GABA Transaminase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 394 |
D2 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 395 |
Chemokine Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 396 |
Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 397 |
GABAA Agonist - Pipeline Insight, 2022 |
Report Link
|
| 398 |
D3 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 399 |
GABAA Modulators - Pipeline Insight, 2022 |
Report Link
|
| 400 |
D3 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 401 |
D4 Agonist - Pipeline Insight, 2022 |
Report Link
|
| 402 |
D4 Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 403 |
Delta Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 404 |
Eg5 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 405 |
Elastase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 406 |
Endothelin Receptor (ET) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 407 |
Endothelin Receptor A (ETA) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 408 |
Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 409 |
Ephrin (EPH) Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 410 |
Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 411 |
Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 412 |
Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2022 |
Report Link
|
| 413 |
Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 414 |
Factor IIa (Thrombin) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 415 |
Factor IX - Pipeline Insight, 2022 |
Report Link
|
| 416 |
Factor IX A Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 417 |
Factor VIIa Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 418 |
Factor VIII Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 419 |
Farnesoid X Receptor (FXR) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 420 |
Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 421 |
NF-Kappa B Inhibitors – Pipeline Insights, 2022 |
Report Link
|
| 422 |
CD137 Agonist Antibody - Pipeline Insight, 2022 |
Report Link
|
| 423 |
C-X-C Chemokine Receptor (CXCR) Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 424 |
RIPK1 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 425 |
Toll-Like Receptor 3 (TLR-3) Agonist - Pipeline Insight, 2022 |
Report Link
|
| 426 |
Relapsed and Refractory CD5-Expressing T Cell Lymphomas - Pipeline Insight, 2022 |
Report Link
|
| 427 |
AXL Kinase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 428 |
Cytidine Deaminase Inhibitors (CDA) - Pipeline Insight, 2022 |
Report Link
|
| 429 |
TIM-3 Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 430 |
Anti-CD22 Therapies - Pipeline Insight, 2022 |
Report Link
|
| 431 |
Anti-CD30 Therapies - Pipeline Insight, 2022 |
Report Link
|
| 432 |
Oncolytic Virus Cancer Therapy - Pipeline Insight, 2022 |
Report Link
|
| 433 |
mTORC1 Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 434 |
Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 435 |
Sphingosine 1 Phosphate Receptor Modulators - Pipeline Insight, 2022 |
Report Link
|
| 436 |
Selective Estrogen Receptor Degraders - Pipeline Insight, 2022 |
Report Link
|
| 437 |
Amyloid Beta-Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 438 |
Protein 50S Ribosomal Subunit Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 439 |
Opioid Kappa Receptor Agonists - Pipeline Insight, 2022 |
Report Link
|
| 440 |
Serotonin 3 Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 441 |
Dopamine D1 Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 442 |
CXCR4 Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 443 |
Complement C1 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 444 |
Type 1 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 445 |
Cannabinoid Receptor CB1 Inverse Agonists - Pipeline Insight, 2022 |
Report Link
|
| 446 |
Acetylcholine Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 447 |
Interleukin 1 Beta Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 448 |
Type 4 Cyclic Nucleotide Phosphodiesterase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 449 |
TYK2 Kinase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 450 |
Histamine H1 Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 451 |
T Type Calcium Channel Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 452 |
Thyroid Hormone Receptor Agonists - Pipeline Insight, 2022 |
Report Link
|
| 453 |
Dipeptidyl Peptidase 4 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 454 |
Serotonin 1B Receptor Agonists - Pipeline Insight, 2022 |
Report Link
|
| 455 |
Proteasome Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 456 |
Sodium Channel Blockers - Pipeline Insight, 2022 |
Report Link
|
| 457 |
Placenta Growth Factor Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 458 |
Alpha-Synuclein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 459 |
14-Alpha Demethylase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 460 |
Complement C5 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 461 |
CD3 Antigen Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 462 |
Epidermal Growth Factor Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 463 |
Exosomes - Pipeline Insight, 2022 |
Report Link
|
| 464 |
HAVCR2 Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 465 |
CD47 Antigen Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 466 |
Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2022 |
Report Link
|
| 467 |
Interleukin 6 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 468 |
Angiotensin Type 1 Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 469 |
Nociceptin Receptor Agonists - Pipeline Insight, 2022 |
Report Link
|
| 470 |
Proto Oncogene Protein c-myc Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 471 |
Thymidylate Synthase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 472 |
Proto Oncogene Protein c-akt Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 473 |
ROS1 Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 474 |
TIGIT Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 475 |
P53 Antigen Modulators - Pipeline Insight, 2022 |
Report Link
|
| 476 |
Discoidin Domain Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 477 |
ANGPTL3 Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 478 |
Poly(ADP-ribose) Polymerase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 479 |
ATR Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 480 |
Coronavirus-3C-like-Proteinase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 481 |
Sigma-1 Receptor Agonists - Pipeline Insight, 2022 |
Report Link
|
| 482 |
Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 483 |
Interleukin 8 Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 484 |
TRAIL Receptor 2 Agonists - Pipeline Insight, 2022 |
Report Link
|
| 485 |
TIE-2 Receptor Agonists - Pipeline Insight, 2022 |
Report Link
|
| 486 |
Vascular Endothelial Growth Factor Receptor-2 Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 487 |
Aminopeptidase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 488 |
Type-2 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 489 |
Vascular Endothelial Growth Factor Receptor 3 Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 490 |
NLRP3 Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 491 |
Apolipoprotein C-III Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 492 |
Aldosterone Synthase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 493 |
Cyclo-Oxygenase 2 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 494 |
Macrophage Colony Stimulating Factor Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 495 |
IgE Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 496 |
Purinoceptor P2Y12 Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 497 |
ACVR1 Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 498 |
MAP Kinase Kinase 1 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 499 |
Capsid Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 500 |
Viral Core Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 501 |
Histone Deacetylase 6 (HDAC 6) Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 502 |
Factor XI Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 503 |
Protein-Tyrosine-Phosphatase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 504 |
Proto-Oncogene Protein c-bcl-2 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 505 |
Complement C3 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 506 |
Interleukin-12 Expression Stimulants - Pipeline Insight, 2022 |
Report Link
|
| 507 |
Proto Oncogene Proteins C PIM 1 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 508 |
Nitric Oxide Synthase Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 509 |
BRD4 Protein Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 510 |
Proto-Oncogene Protein c mdm2 Inhibitors - Pipeline Isnight, 2022 |
Report Link
|
| 511 |
TRPV1 Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 512 |
Notch Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 513 |
Endothelial PAS Domain-Containing Protein 1 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 514 |
CD33 Antigen Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 515 |
ERBB 2 Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 516 |
MALT1 Protein Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 517 |
MCL1 Protein Inhibitor - Pipeline Insight, 2022 |
Report Link
|
| 518 |
Alpha4beta7 Integrin Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 519 |
Interleukin 4 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 520 |
Complement C1s Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 521 |
Neonatal Fc Receptor Antagonists- Pipeline Insight, 2022 |
Report Link
|
| 522 |
MPYS Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 523 |
Enoyl-ACP Reductase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 524 |
MPYS Protein Stimulants - Pipeline Insight, 2022 |
Report Link
|
| 525 |
PRMT5 Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 526 |
Hematopoietic Progenitor Kinase 1 Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 527 |
Phosphatidylinositol 3 Kinase Delta Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 528 |
TrkC Receptor Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 529 |
Type II DNA Topoisomerase inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 530 |
DNA Topoisomerase I Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 531 |
Ribonucleotide Reductase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 532 |
WEE1 Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 533 |
Protein Tyrosine Phosphatase Non Receptor Type 11 Antagonists - Pipeline Insight, 2022 |
Report Link
|
| 534 |
DUX4 Protein Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 535 |
P38 Mitogen-Activated Protein (MAP) Kinase Inhibitors - Pipeline Insight, 2022 |
Report Link
|
| 536 |
RNA Interference- Pipeline Insight, 2022 |
Report Link
|
